LTFS
LUMO

Ladenburg Thalmann Financial Services’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$26K Buy
1,152
+1,111
+2,710% +$15.8K ﹤0.01% 3992
2019
Q3 		$1K Hold
41
– – ﹤0.01% 5177
2019
Q2 		$1K Hold
41
– – ﹤0.01% 5175
2019
Q1 		$1K Hold
41
– – ﹤0.01% 5130
2018
Q4 		$1K Sell
41
-33
-45% -$581 ﹤0.01% 5110
2018
Q3 		$2K Hold
74
– – ﹤0.01% 4916
2018
Q2 		$5K Hold
74
– – ﹤0.01% 4610
2018
Q1 		$5K Hold
74
– – ﹤0.01% 4610
2017
Q4 		$5K Hold
74
– – ﹤0.01% 4537
2017
Q3 		$7K Sell
74
-43
-37% -$3.3K ﹤0.01% 4271
2017
Q2 		$8K Buy
117
+31
+36% +$3.84K ﹤0.01% 4150
2017
Q1 		$18K Sell
86
-50
-37% -$7.14K ﹤0.01% 3626
2016
Q4 		$13K Sell
136
-22
-14% -$2.48K ﹤0.01% 3745
2016
Q3 		$22K Sell
158
-29
-16% -$2.88K ﹤0.01% 3348
2016
Q2 		$19K Sell
187
-66
-26% -$8.18K ﹤0.01% 3381
2016
Q1 		$41K Sell
253
-26
-9% -$5.27K ﹤0.01% 2745
2015
Q4 		$91K Buy
279
+117
+72% +$38.1K ﹤0.01% 2138
2015
Q3 		$52K Buy
162
+140
+636% +$61.5K ﹤0.01% 2445
2015
Q2 		$9K Sell
22
-15
-41% -$6.37K ﹤0.01% 3772
2015
Q1 		$18K Buy
37
+22
+147% +$8.53K ﹤0.01% 3266
2014
Q4 		$5K Sell
15
-33
-69% -$9.82K ﹤0.01% 3758
2014
Q3 		$9K Buy
48
+7
+17% +$1.54K ﹤0.01% 3176
2014
Q2 		$10K Sell
41
-253
-86% -$51.4K ﹤0.01% 3089
2014
Q1 		$75K Buy
294
+12
+4% +$3.67K ﹤0.01% 1681
2013
Q4 		$56K Buy
282
+1
+0.4% +$178 ﹤0.01% 1840
2013
Q3 		$47K Buy
281
+2
+0.7% +$322 ﹤0.01% 1868
2013
Q2 		$50K Buy
+279
New +$39.5K ﹤0.01% 1740

Other funds holding LUMO

LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ladenburg Thalmann Financial Services's LUMO Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Lumos Pharma, Inc. Common Stock (LUMO) stake by 2,710% in Q4 2019, buying an estimated $15.8K and bringing the position to 1,152 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #3992.

Ladenburg Thalmann Financial Services first reported a position in LUMO in Q2 2013 and has held it in 27 quarters since. The position peaked at $91K in Q4 2015. 64 funds tracked by Wall St. Rank hold LUMO as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,152 shares of Lumos Pharma, Inc. Common Stock worth $26K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 1,111 Lumos Pharma, Inc. Common Stock shares in Q4 2019, an estimated $15.8K.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3992 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Lumos Pharma, Inc. Common Stock position peaked at $91K in Q4 2015.
  • 64 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.